Navigation Links
In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team
Date:1/19/2010

Kris Freeman hopes for first U.S. cross-country medal since 1976; health issues plagued 2006 Olympic bid

INDIANAPOLIS, Jan. 19 /PRNewswire-USNewswire/ -- Kris Freeman is back in the hunt for an Olympic medal in Vancouver after being named today to the U.S. ski team following a disappointing finish at the 2006 Games in Torino, Italy.  Freeman, who is expected to compete in up to five events at the 2010 Games in February, suffers from type 1 diabetes, a form of the disease where the body does not produce insulin needed to regulate blood sugar.  Freeman is sponsored by Eli Lilly Company (Lilly), which makes the insulin that he depends on as a life-saving treatment.

Freeman is expected to compete for a medal in as many as five Olympic events spanning the breadth of the Vancouver Games, including the 15 km freestyle, the individual sprint, the 30 km pursuit, the team sprint, and the 50 km mass start classic.  Bill Koch won a silver medal in cross-country skiing in the 1976 Innsbruck Games in Austria, the only American to have medaled in the sport.

A key marker on Freeman's comeback trail is how he is now treated for type 1 diabetes.  To compete in the 2010 Games, Freeman will wear a small device, called an insulin pump, which provides an adjustable supply of insulin to help manage his diabetes even while racing.  

Diagnosed with type 1 diabetes in 2000 at age 19, Freeman was told he would never be able to compete as an Olympian because of his diabetes.

"I'm motivated to win for my country and myself, but to also prove to detractors that it's possible to compete against the world's best cross-country skiers, even with type 1 diabetes," said Freeman.

Freeman's return to elite competition is even more anticipated after he contracted the flu during the 2006 Games and underwent surgery in both legs last spring to alleviate debilitating pain caused by a rare muscle disorder called compartment syndrome.

Off the snow, Freeman focuses on diabetes education. He travels for sponsor Eli Lilly and Company to children's diabetes camps across the U.S. to speak to campers about their disease. To date, he has met with more than 3,000 youngsters nationwide.

"I have a blast meeting the campers, but more importantly, I want them to see that a person with diabetes can do almost anything he or she puts his mind to, including competing in the Olympics," said Freeman.

In competition, Freeman is a 13-time U.S. National cross-country champion and recently had his best finish at the 2009 World Championships and the best U.S. finish in any cross-country event in more than two decades. He came in fourth in November's World Cup 15 km classic in Kuusamo, Finland.

At the 2002 Olympics in Salt Lake City, Freeman placed 22nd in the 15 km classic and 14th in the 30 km pursuit. He also logged the sixth fastest time overall in the 4 x 10 km team relay, helping the U.S. team secure fifth place — the best Olympic finish for the U.S. cross-country team in history. In 2003, Freeman finished sixth and fifth in two consecutive World Cups, and finished 22nd in the 15 km classic at the 2006 Winter Games in Torino, Italy.

For more information about Freeman's work with Lilly, please visit www.lillydiabetes.com. For the full 2010 U.S. Olympic cross-country event schedule visit www.vancouver2010.com/olympic-cross-country-skiing.

About Lilly Diabetes

For more than 85 years, Eli Lilly and Company (Lilly) has been a worldwide leader in pioneering industry-leading solutions to support people living with and treating diabetes. Lilly introduced the world's first commercial insulin in 1923, and remains at the forefront of medical and delivery device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy -- practical tools, education and support programs to help overcome barriers to success along the diabetes journey. At Lilly, the journey of each person living with or treating diabetes inspires ours. For more information, visit www.lillydiabetes.com.

About Eli Lilly and Company

Eli Lilly and Company, a leading innovation-driven company, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Information about Lilly is available at www.lilly.com.

SOURCE Eli Lilly and Company

RELATED LINKS
http://www.lillydiabetes.com
http://www.lilly.com

'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Cross-Country Walker to Finish His Journey for Cancer Research
2. Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones
3. Elite Skier Uses OmniPod(R) Insulin Management System at World Championships
4. Weekend Admission May Be Riskier for GI Bleeding
5. Adverse housing conditions contribute to diabetes risk
6. RAND finds cases of undiagnosed diabetes drop sharply
7. UCLA researchers identify markers that may predict diabetes in still-healthy people
8. Diabetes appears to increase risk of death for patients with acute coronary syndromes
9. Discovery of sugar sensor in intestine could benefit diabetes
10. Despite overeating, morbidly obese mice gain protection against diabetes
11. Heart Attack Boosts Diabetes Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release of ... in Cannes (France), XO Private has initiated a second print-run of its lavish luxury ... a metre across when open, weighs in at more than six kilos, retails at ...
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could it ... the United States may be taken over by technology in the next five to ... over colleagues is drawing to a close. Success will belong to those who can ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ... is so critically important that we all are aware of our options and ... is proud to announce the launch of its newest edition of "Vision and ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: